Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
56,624,501
-
Share change
-
-463,149
-
Total reported value
-
$7,550,200,943
-
Put/Call ratio
-
64%
-
Price per share
-
$133.29
-
Number of holders
-
432
-
Value change
-
-$94,365,268
-
Number of buys
-
195
-
Number of sells
-
185
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q3 2022
As of 30 Sep 2022 Jazz Pharmaceuticals plc - SHS USD (JAZZ) had 432 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 56,624,501 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, JPMORGAN CHASE & CO, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, LSV ASSET MANAGEMENT, Polaris Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, FRANKLIN RESOURCES INC, and JANUS HENDERSON GROUP PLC.
This table shows 439 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.